Coronary artery disease and coronary angioplasty in chronic hemodialysis patients;Coronaropathie et angioplastie coronaire dans l'insuffisance rénale dialysée

Annales de Cardiologie et d'Angeiologie

Volumn 56, Issue 1, 2007, Pages 10-15

  Benamer, H ^a,b   Lefevre J J ^a   Debure, A ^a   Gaultier, C ^a,b  

^a Hopital Europeen de Paris   (France)

^b FOCH HOSPITAL   (France)

Author keywords

Atherosclerosis; Coronary angioplasty; Coronary artery disease; Hemodialysis; Prognosis; Renal insufficiency

Indexed keywords

ATHEROSCLEROSIS; CHRONIC KIDNEY FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG ELUTING STENT; HEMODIALYSIS; HIGH RISK POPULATION; HUMAN; ISCHEMIA; MORTALITY; PATHOLOGY; POPULATION DISTRIBUTION; PRODUCTIVITY; PROGNOSIS; RESTENOSIS; SHORT SURVEY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; CORONARY ARTERY ATHEROSCLEROSIS; RENAL REPLACEMENT THERAPY; REVIEW; STENT;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERIOSCLEROSIS; CORONARY RESTENOSIS; DIABETES COMPLICATIONS; HUMANS; KIDNEY FAILURE, CHRONIC; PROGNOSIS; RENAL DIALYSIS; STENTS;

EID: 33845918739     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2006.11.002     Document Type: Short Survey

References (38)

1. Culleton B.F., Larson M.G., Wilson P.W., Evans J.C., Parfrey P.S., and Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int. 56 6 (1999) 2214-2219
2. Kahan B.D. The emerging matrix of immunosuppressive agents. Transplant. Proc. 35 6 (2003) 2365-2368
3. Lindner A., Charra B., Sherrard D.J., and Scribner B.H. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N. Engl. J. Med. 290 13 (1974) 697-701
4. Mailloux L.U., and Haley W.E. Hypertension in the ESRD patient: pathophysiology, therapy, outcomes, and future directions. Am. J. Kidney Dis. 32 5 (1998) 705-719
5. Bleyer A.J., Russell G.B., and Satko S.G. Sudden and cardiac death rates in hemodialysis patients. Kidney Int. 55 4 (1999) 1553-1559
6. Agarwal R. Management of hypertension in hemodialysis patients. Hemodial Int 10 3 (2006) 241-248
7. Lee C.H., Chang H.W., Wang I.K., Lin C.L., Chen T.C., Wang P.H., et al. Diabetes mellitus, hyperhomocystinemia and atherosclerotic vascular disease in Taiwanese chronic hemodialysis patients: a retrospective study. Ren. Fail. 26 3 (2004) 317-323
8. Shlipak M.G., Fried L.F., Crump C., Bleyer A.J., Manolio T.A., Tracy R.P., et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107 1 (2003) 87-92
9. Block G.A., Hulbert-Shearon T.E., Levin N.W., and Port F.K. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am. J. Kidney Dis. 31 4 (1998) 607-617
10. Robinson K., Gupta A., Dennis V., Arheart K., Chaudhary D., Green R., et al. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation 94 11 (1996) 2743-2748
11. Moustapha A., Naso A., Nahlawi M., Gupta A., Arheart K.L., Jacobsen D.W., et al. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 97 2 (1998) 138-141
12. Foley R.N., Parfrey P.S., Harnett J.D., Kent G.M., Murray D.C., and Barre P.E. The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am. J. Kidney Dis. 28 1 (1996) 53-61
13. Locatelli F., Conte F., and Marcelli D. The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity--the experience of the Lombardy Dialysis Registry. Nephrol. Dial. Transplant. 13 7 (1998) 1642-1644
14. Sarnak M.J., Levey A.S., Schoolwerth A.C., Coresh J., Culleton B., Hamm L.L., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108 17 (2003) 2154-2169
15. I. The USRDS and its products. Am. J. Kidney Dis. 34 2 Suppl 1 (1999) S20-S39
16. Who's Who in the Usrds. Am. J. Kidney Dis. 34 2 Suppl 1 (1999) S4-S6
17. Rigatto C., Foley R., Jeffery J., Negrijn C., Tribula C., and Parfrey P. Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. J. Am. Soc. Nephrol. 14 2 (2003) 462-468
18. Langford E.J., de Belder A.J., Cairns H., Hendry B.M., and Wainwright R.J. Non-invasive cardiac investigations in patients awaiting renal transplantation. J. R. Soc. Med. 90 3 (1997) 136-137
19. Dahan M., Viron B.M., Faraggi M., Himbert D.L., Lagallicier B.J., Kolta A.M., et al. Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patients. Kidney Int. 54 1 (1998) 255-262
20. Reis G., Marcovitz P.A., Leichtman A.B., Merion R.M., Fay W.P., Werns S.W., et al. Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease. Am. J. Cardiol. 75 10 (1995) 707-710
21. Hunold P., Vogt F.M., Heemann U.W., Zimmermann U., and Barkhausen J. Myocardial mass and volume measurement of hypertrophic left ventricles by MRI-study in dialysis patients examined before and after dialysis. J. Cardiovasc. Magn. Reson. 5 4 (2003) 553-561
22. Kuettner A., Trabold T., Schroeder S., Feyer A., Beck T., Brueckner A., et al. Noninvasive detection of coronary lesions using 16-detector multislice spiral computed tomography technology: initial clinical results. J. Am. Coll. Cardiol. 44 6 (2004) 1230-1237
23. Kuettner A., Kopp A.F., Schroeder S., Rieger T., Brunn J., Meisner C., et al. Diagnostic accuracy of multidetector computed tomography coronary angiography in patients with angiographically proven coronary artery disease. J. Am. Coll. Cardiol. 43 5 (2004) 831-839
24. Fujimoto N., Iseki K., Tokuyama K., Tamashiro M., and Takishita S. Significance of coronary artery calcification score (CACS) for the detection of coronary artery disease (CAD) in chronic dialysis patients. Clin. Chim. Acta 367 1-2 (2006) 98-102
25. Golebiowski T., Weyde W., Krajewska M., Kazimierczak K., Derkacz A., Nowicki P., et al. [Coronary heart disease in patients with end-stage renal disease on maintenance dialysis. Part I: epidemiology, pathology of atherosclerosis, and diagnosis]. Postepy Hig Med Dosw (Online) 60 (2006) 286-289
26. Golebiowski T., Weyde W., Krajewska M., Kazimierczak K., Derkacz A., Nowicki P., et al. [Coronary heart disease in patients with end-stage renal disease on maintenance dialysis. Part II: prophylaxis and treatment]. Postepy Hig Med Dosw (Online) 60 (2006) 290-294
27. Ammirati A.L., Dalboni M.A., Cendoroglo M., Draibe S.A., and Fernandes Canziani M.E. Coronary artery calcification, systemic inflammation markers and mineral metabolism in a peritoneal dialysis population. Nephron Clin. Pract. 104 1 (2006) c33-c40
28. Russo D., Palmiero G., De Blasio A.P., Balletta M.M., and Andreucci V.E. Coronary artery calcification in patients with CRF not undergoing dialysis. Am. J. Kidney Dis. 44 6 (2004) 1024-1030
29. Patsalas S., Eleftheriadis T., Spaia S., Theodoroglou H., Panou E., Liakopoulos V., et al. The value of computed tomography-derived coronary artery calcification score in coronary artery disease detection in asymptomatic hemodialysis patients. Ren. Fail. 27 6 (2005) 683-688
30. Le Feuvre C., Dambrin G., Helft G., Tabet S., Beygui F., Legendre C., et al. Comparison of clinical outcome following coronary stenting or balloon angioplasty in dialysis versus non-dialysis patients. Am. J. Cardiol. 85 11 (2000) 1365-1368
31. Hemmelgarn B.R., Ghali W.A., Quan H., Brant R., Norris C.M., Taub K.J., et al. Poor long-term survival after coronary angiography in patients with renal insufficiency. Am. J. Kidney Dis. 37 1 (2001) 64-72
32. Rubenstein M.H., Harrell L.C., Sheynberg B.V., Schunkert H., Bazari H., and Palacios I.F. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?. Circulation 102 24 (2000) 2966-2972
33. Herzog C.A., Ma J.Z., and Collins A.J. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 106 17 (2002) 2207-2211
34. Le Feuvre C., Dambrin G., Helft G., Beygui F., Touam M., Grunfeld J.P., et al. Clinical outcome following coronary angioplasty in dialysis patients: a case-control study in the era of coronary stenting. Heart 85 5 (2001) 556-560
35. Le Feuvre C., Montalescot G., Rosey G., Collet J.P., Beygui F., Choussat R., et al. Predictive factors of cardiac events after implantation of sirolimus-eluting stents for treatment of in-stent restenosis. Int. J. Cardiol. 109 2 (2006) 207-212
36. Moussa I., Leon M.B., Baim D.S., O'Neill W.W., Popma J.J., Buchbinder M., et al. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 109 19 (2004) 2273-2278
37. Hassani S.E., Chu W.W., Wolfram R.M., Kuchulakanti P.K., Xue Z., Gevorkian N., et al. Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients. J. Invasive Cardiol. 18 6 (2006) 273-277
38. Dewey T.M., Herbert M.A., Prince S.L., Robbins C.L., Worley C.M., Magee M.J., et al. Does coronary artery bypass graft surgery improve survival among patients with end-stage renal disease?. Ann. Thorac. Surg. 81 2 (2006) 591-598 (discussion 598)